相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
Mina Lee et al.
CLINICAL GENITOURINARY CANCER (2019)
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J. T. Lear et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Synthesis and evaluation of novel dimethylpyridazine derivatives as hedgehog signaling pathway inhibitors
Chenglin Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naive and Previously Treated Basal Cell Carcinoma
Johanna Bendell et al.
CLINICAL CANCER RESEARCH (2018)
Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Michael R. Savona et al.
CLINICAL CANCER RESEARCH (2018)
Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis
Pingxing Xie et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas
Jason M. Rizzo et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results
Jorge E. Cortes et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
N. Basset-Seguin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Miroslava Didiasova et al.
FASEB JOURNAL (2017)
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
A. Stathis et al.
INVESTIGATIONAL NEW DRUGS (2017)
Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib
Tina Bhutani et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
Brigitte Dreno et al.
LANCET ONCOLOGY (2017)
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Mark W. Kieran et al.
NEURO-ONCOLOGY (2017)
Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
Christiana Polydorou et al.
ONCOTARGET (2017)
Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia
Emily-Marie Latuske et al.
ONCOTARGET (2017)
Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
Wei-Jie Zou et al.
MEDICAL SCIENCE MONITOR (2017)
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment
Ghassan K. Abou-Alfa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Aleksandar Sekulic et al.
BMC CANCER (2017)
An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
Christina Danial et al.
CLINICAL CANCER RESEARCH (2016)
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSA
R. Houot et al.
ANNALS OF ONCOLOGY (2016)
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Takekazu Iwata et al.
ANNALS OF THORACIC SURGERY (2016)
Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells
Md Maksudul Alam et al.
BMC CANCER (2016)
The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
Melanie Mediavilla-Varela et al.
BMC CANCER (2016)
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)
Chandra P. Belani et al.
CANCER (2016)
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
Benjamin L. Maughan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
Hironobu Minami et al.
CANCER SCIENCE (2016)
Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells
Nobuaki Fukushima et al.
CANCER SCIENCE (2016)
Primary cilia are present on human blood and bone marrow cells and mediate Hedgehog signaling
Mohan Singh et al.
EXPERIMENTAL HEMATOLOGY (2016)
Emerging from their burrow: Hedgehog pathway inhibitors for cancer
Gregory N. Gan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Update to an open-label clinical trial of vismodegib as neoadjuvant before surgery for high-risk basal cell carcinoma (BCC)
Gina P. Kwon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Jean Y. Tang et al.
LANCET ONCOLOGY (2016)
A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
M. Catherine Pietanza et al.
LUNG CANCER (2016)
A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma
Daniel W. Bowles et al.
ORAL ONCOLOGY (2016)
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
Andrew H. Ko et al.
PANCREAS (2016)
In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
Monica Benvenuto et al.
ONCOTARGET (2016)
Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1
Anmada Nayak et al.
SCIENTIFIC REPORTS (2016)
Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma
Yuqiong Wang et al.
JOURNAL OF CANCER (2016)
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
Mina S. Ally et al.
JAMA DERMATOLOGY (2016)
Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma
Shalini V. Mohan et al.
JAMA DERMATOLOGY (2016)
Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy
Laura Di Magno et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
M. Zuo et al.
BRITISH JOURNAL OF CANCER (2015)
Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects
Jasmin Wellbrock et al.
CLINICAL CANCER RESEARCH (2015)
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer
Carminia Maria Della Corte et al.
CLINICAL CANCER RESEARCH (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
Howard Sofen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
GLI2 inhibition abrogates human leukemia stem cell dormancy
Anil Sadarangani et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
Nicole Basset-Seguin et al.
LANCET ONCOLOGY (2015)
Phase II evaluation of IPI-926, an oral Hedgehog inhibitor, in patients with myelofibrosis
Koji Sasaki et al.
LEUKEMIA & LYMPHOMA (2015)
Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
Annelies Gonnissen et al.
ONCOTARGET (2015)
PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth
Narinder Sharma et al.
ONCOTARGET (2015)
Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer
Namrata Bora-Singhal et al.
NEOPLASIA (2015)
A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
Andrew J. Wagner et al.
CLINICAL CANCER RESEARCH (2015)
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
C. D'Amato et al.
BRITISH JOURNAL OF CANCER (2014)
Pyrvinium Attenuates Hedgehog Signaling Downstream of Smoothened
Bin Li et al.
CANCER RESEARCH (2014)
Hedgehog Signaling Drives Radioresistance and Stroma-Driven Tumor Repopulation in Head and Neck Squamous Cancers
Gregory N. Gan et al.
CANCER RESEARCH (2014)
A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
Jordi Rodon et al.
CLINICAL CANCER RESEARCH (2014)
Hedgehog-GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
Lingling Huang et al.
CLINICAL CANCER RESEARCH (2014)
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Edward J. Kim et al.
CLINICAL CANCER RESEARCH (2014)
The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer
Kevin R. Ginnebaugh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma
Jiancheng Zhou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers
Jun Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Daniel J. Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Yujie Tang et al.
NATURE MEDICINE (2014)
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
R. Santini et al.
ONCOGENE (2014)
Canonical and non-canonical Hedgehog signalling and the control of metabolism
Raffaele Teperino et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
Ritesh K. Srivastava et al.
ONCOTARGET (2014)
Significance of glioma-associated oncogene homolog 1 (GLI1) expression in claudin-low breast cancer and crosstalk with the nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway
Sierra A. Colavito et al.
BREAST CANCER RESEARCH (2014)
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
A. Italiano et al.
ANNALS OF ONCOLOGY (2013)
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential
Patricia M. LoRusso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft
Junsheng Fu et al.
CANCER LETTERS (2013)
Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer
Stephen B. Keysar et al.
CANCER RESEARCH (2013)
Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells
Shingo Kozono et al.
CANCER RESEARCH (2013)
A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
Jordan Berlin et al.
CLINICAL CANCER RESEARCH (2013)
Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
Antonio Jimeno et al.
CLINICAL CANCER RESEARCH (2013)
Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
Amar Gajjar et al.
CLINICAL CANCER RESEARCH (2013)
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo
Malin Wickstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Hedgehog Pathway Inhibition Radiosensitizes Non-Small Cell Lung Cancers
Jing Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Transcriptional Regulation of Serine/Threonine Protein Kinase (AKT) Genes by Glioma-associated Oncogene Homolog 1
Nitin K. Agarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Charles M. Rudin et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Noncanonical Regulation of the Hedgehog Mediator GLI1 by c-MYC in Burkitt Lymphoma
Joon Won Yoon et al.
MOLECULAR CANCER RESEARCH (2013)
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Dereck Amakye et al.
NATURE MEDICINE (2013)
NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Junsheng Fu et al.
NEURO-ONCOLOGY (2013)
Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation
F. Wolff et al.
ONCOGENE (2013)
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis et al.
ONCOLOGIST (2013)
Hedgehog Signaling Regulates Telomerase Reverse Transcriptase in Human Cancer Cells
Tapati Mazumdar et al.
PLOS ONE (2013)
Suppression of growth and migration by blocking the hedgehog signaling pathway in gastric cancer cells
Runwei Yan et al.
CELLULAR ONCOLOGY (2013)
Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
Anne Lynn S. Chang et al.
ARCHIVES OF DERMATOLOGY (2012)
Hedgehog pathway regulators influence cervical cancer cell proliferation, survival and migration
Ivana Samarzija et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Yan Wang et al.
CANCER CELL (2012)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Stanley B. Kaye et al.
CLINICAL CANCER RESEARCH (2012)
Expression of Glioma-associated Oncogene Homolog 1 is Associated with Invasion and Postoperative Liver Metastasis in Colon Cancer
Yin-lu Ding et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
Adam D. Steg et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin
Deng Pan et al.
LEUKEMIA RESEARCH (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radiation induces epithelial-mesenchymal transition in colorectal cancer cells
Aya Kawamoto et al.
ONCOLOGY REPORTS (2012)
Hedgehog Pathway Signaling Regulates Human Colon Carcinoma HT-29 Epithelial Cell Line Apoptosis and Cytokine Secretion
Agnes N. Yoshimoto et al.
PLOS ONE (2012)
The Hedgehog Signal Transduction Network
David J. Robbins et al.
SCIENCE SIGNALING (2012)
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
Michael J. Munchhof et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
Curtis A. Thacker et al.
CANCER MEDICINE (2012)
Hedgehog Signaling Drives Cellular Survival in Human Colon Carcinoma Cells
Tapati Mazumdar et al.
CANCER RESEARCH (2011)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
Glioma-Associated Oncogene Family Zinc Finger 1 Expression and Metastasis in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiation Therapy (RTOG 9003)
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma
Ming Yan et al.
ORAL ONCOLOGY (2011)
Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling
Qipeng Fan et al.
Chinese Journal of Cancer (2011)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas
Frederic Varnat et al.
EMBO MOLECULAR MEDICINE (2010)
Requirement of TGFβ Signaling for SMO-mediated Carcinogenesis
Qipeng Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma
Astrid De Boeck et al.
ORAL ONCOLOGY (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
Silvia Buonamici et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Cross talk between hedgehog and epithelial-mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers
H. Ohta et al.
BRITISH JOURNAL OF CANCER (2009)
Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN Pathway
Harald Schnidar et al.
CANCER RESEARCH (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved
Miao-Hsueh Chen et al.
GENES & DEVELOPMENT (2009)
Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus
Noriyuki Isohata et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
Joel M. Hyman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
Nawneet K. Kurrey et al.
STEM CELLS (2009)
Hedgehog Signaling in Development and Cancer
Jin Jiang et al.
DEVELOPMENTAL CELL (2008)
Cancer stem cells in head and neck squamous cell cancer
Mark E. P. Prince et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-β-mediated activation of the ALK5-Smad 3 pathway
Young A. Yoo et al.
CARCINOGENESIS (2008)
Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (Review)
Yuriko Katoh et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2008)
Induction of sonic hedgehog mediators by transforming growth factor-β:: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo
Sylviane Dennler et al.
CANCER RESEARCH (2007)
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Matthias Lauth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells
Zhenyu Ji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Pirfenidone inhibits TGF-β expression in malignant glioma cells
Isabel Burghardt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
Craig D. Peacock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity
Virginie Clement et al.
CURRENT BIOLOGY (2007)
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development
U Tostar et al.
JOURNAL OF PATHOLOGY (2006)
Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma
Yukiko Mori et al.
ONCOLOGY (2006)
In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice
P Sanchez et al.
MECHANISMS OF DEVELOPMENT (2005)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
SS Karhadkar et al.
NATURE (2004)
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
DM Berman et al.
NATURE (2003)
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
DN Watkins et al.
NATURE (2003)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)
分享论文
